HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip Haaf Selected Research

trans-crotonin (CTN)

1/2022Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.
5/2021External validation of the clinical chemistry score.
3/2017Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.
11/2016Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction.
9/2015Early rule-out and rule-in of myocardial infarction using sensitive cardiac Troponin I.
6/2015Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin.
1/2015Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction.
9/2014Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction.
2/2014Accuracy of very low concentration of cTn, below the 99th, for the diagnosis of acute myocardial infarction: comments about Lippi's and coll. letter.
2/2014Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip Haaf Research Topics

Disease

38Myocardial Infarction
01/2022 - 05/2011
23Chest Pain (Chest Pains)
10/2021 - 05/2011
7Acute Coronary Syndrome
03/2017 - 09/2011
5Coronary Artery Disease (Coronary Atherosclerosis)
06/2022 - 04/2012
3Non-ST Elevated Myocardial Infarction
04/2015 - 09/2014
2Myocarditis (Carditis)
01/2022 - 10/2021
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 11/2016
2Inflammation (Inflammations)
10/2021 - 01/2019
2Infarction (Infarctions)
01/2021 - 07/2017
2Heart Diseases (Heart Disease)
03/2017 - 11/2014
2Ischemia
01/2017 - 08/2011
2Fibrosis (Cirrhosis)
12/2016 - 11/2016
2Necrosis
03/2013 - 08/2011
2Myocardial Ischemia (Ischemic Heart Diseases)
08/2011 - 05/2011
1Muscular Diseases (Myopathy)
01/2022
1Myositis (Idiopathic Inflammatory Myopathies)
01/2022
1COVID-19
10/2021
1Infections
10/2021
1Pericarditis
10/2021
1Amyloidosis
10/2020
1Atrial Fibrillation
07/2019
1Abdominal Pain (Pain, Abdominal)
01/2019
1Peripheral Arterial Disease
10/2017
1Bundle-Branch Block (Fascicular Block)
02/2017
1Aortic Valve Stenosis (Aortic Stenosis)
02/2017
1Cicatrix (Scar)
11/2016
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Bronchitis
11/2014
1Pneumonia (Pneumonitis)
11/2014
1Gastroesophageal Reflux (GERD)
11/2014
1Heart Failure
12/2013
1Cardiovascular Diseases (Cardiovascular Disease)
10/2013
1Unstable Angina
03/2013
1Hypoxia (Hypoxemia)
02/2013
1Hypertension (High Blood Pressure)
05/2012
1Chronic Renal Insufficiency
05/2012
1Renal Insufficiency (Renal Failure)
10/2011

Drug/Important Bio-Agent (IBA)

29TroponinIBA
01/2022 - 06/2011
23trans-crotonin (CTN)IBA
01/2022 - 06/2011
18Troponin T (Troponin T1)IBA
10/2021 - 05/2011
12Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2012
9Brain Natriuretic Peptide (Natrecor)FDA Link
10/2017 - 05/2011
7Troponin IIBA
03/2021 - 10/2013
3Natriuretic PeptidesIBA
10/2021 - 04/2012
3GadoliniumIBA
07/2017 - 11/2016
2Messenger RNA (mRNA)IBA
01/2022 - 10/2021
2omega-Chloroacetophenone (Mace)IBA
04/2015 - 10/2013
2pro-brain natriuretic peptide (1-76)IBA
02/2014 - 08/2011
1trimethyloxamine (trimethylamine N-oxide)IBA
06/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1regadenosonFDA Link
01/2022
1Cytidine Monophosphate (CMP)IBA
01/2022
1mRNA VaccinesIBA
10/2021
1VaccinesIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
05/2021
1Prealbumin (Transthyretin)IBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
01/2019
1ProcalcitoninIBA
01/2019
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2017
1MyoglobinIBA
12/2015
1AntibodiesIBA
04/2015
1Immunoglobulin G (IgG)IBA
04/2015
1Immunoglobulin M (IgM)IBA
04/2015
1AutoantibodiesIBA
04/2015
1Apolipoproteins AIBA
04/2015
1Phosphorylcholine (Phosphocholine)IBA
04/2015
1Apolipoprotein A-I (Apolipoprotein A1)IBA
04/2015
1Adenosine Diphosphate (ADP)IBA
04/2015
1C-terminal proendothelin-1IBA
02/2014
1AdrenomedullinIBA
09/2013
1Fatty Acid-Binding ProteinsIBA
05/2013
1Trinitrotoluene (TNT)IBA
05/2013
1Uric Acid (Urate)IBA
02/2013
1EpitopesIBA
04/2012
1Growth Differentiation Factor 15IBA
02/2012
1Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
01/2012
1C-Reactive ProteinIBA
01/2012
1Peroxidase (Myeloperoxidase)IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2012

Therapy/Procedure

3Therapeutics
01/2021 - 12/2013
1Catheter Ablation
07/2019
1Catheters
02/2017
1Aftercare (After-Treatment)
02/2017
1Transcatheter Aortic Valve Replacement
12/2016